CORAL HENKEL: Open Payments
NPI 1770150666 · OLDSMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 53 payments from 15 companies in 2025. Trend: 2023 $829 · 2024 $1,584 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $392 |
| Janssen Biotech, Inc. | 10 | $242 |
| Madrigal Pharmaceuticals | 4 | $161 |
| Gilead Sciences, Inc. | 5 | $145 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| PFIZER INC. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, ZENPEP, LINZESS, XIFAXAN, CREON.
Industry payments across FL — which companies pay providers there.
